Table 4.
The IC50 and CR of ZEN-specific antibodies reported in previous literature.
| References | ZEN mAb | Coupling Method | Mode | IC50 of ZEN (μg/L) | CR (%) a | ||||
|---|---|---|---|---|---|---|---|---|---|
| α-ZAL | β-ZAL | α-ZOL | β-ZOL | ZON | |||||
| This study | mAb 2B6 | AGA | icELISA b | 10.38 | 1.52 | 1.28 | 2.64 | 1.83 | 4.27 |
| Sun et al. (2014) [34] | mAb 4A3 | BDE | icELISA | 1.115 | 3.854 | 1.709 | 2.499 | 2.800 | 53.121 |
| Burmistrova et al. (2009) [35] | mAb 2D8 | OAE | dcELISA c | 0.8 | 69 | <1 | 42 | <1 | 22 |
| Gao et al. (2012) [33] | mAb # d | FA | icELISA | 55.72 | 0.63 | 0.92 | 0.65 | 0.94 | 1.48 |
| Teshima et al. (1990) [25] | mAb 7-1-144 | AGA | icELISA | 11.2 | <0.1 | <0.1 | 0.9 | <0.1 | 4.0 |
Note: (a) The data were calculated using the CR values of ZEN as 100%; (b) icELISA: indirect competitive enzyme-linked immunosorbent assay; (c) dcELISA: direct competitive enzyme-linked immunosorbent assay; (d) #: unnamed.